Major Depressive Disorder

• FDA approval · 2006-06-14
  FDA Approved: CITALOPRAM — Original Application (Chartwell Governmental & Specialty RX, LLC.)

  FDA approves the original application for generic citalopram, with Chartwell Governmental & Specialty RX, LLC as the manufacturer.

• CLINICAL_TRIALS trial_result · 2006-06-09
  Clinical Trial Update: A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Phase 4]

  A Phase 4 placebo-controlled trial of ropinirole for refractory bipolar depression is being conducted at Sheba Medical Center; the trial sta…

• CLINICAL_TRIALS trial_result · 2006-05-22
  Clinical Trial Update: Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression [Phase 3]

  A Phase 3 trial evaluating an anti-Toxoplasma gondii add-on therapy in Toxoplasma seropositive individuals with schizophrenia or major depre…

• FDA approval · 2006-05-19
  FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for desipramine hydrochloride from Actavis Pharma, Inc., authorizing continued marketing of the gene…

• FDA approval · 2006-05-19
  FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for desipramine hydrochloride from Actavis Pharma, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-05-19
  FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for Desipramine Hydrochloride from Actavis Pharma, Inc. This action confirms regulatory approval…

• CLINICAL_TRIALS trial_result · 2006-05-18
  Clinical Trial Update: Use of Risperidone in ECT for Treatment Resistant Depression [Phase 4]

  Phase 4 trial evaluating risperidone augmentation with electroconvulsive therapy for treatment-resistant depression was terminated.

• FDA approval · 2006-05-04
  FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

  The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig. The approval updates the product's la…